Stephanie McMillan
Overview
Explore the profile of Stephanie McMillan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khalil N, McMillan S, Benbadis S, Robertson D
Epilepsy Behav
. 2021 Jan;
115:107725.
PMID: 33434883
Hmong communities originated in China but today are located across the globe. Salvation, health, and well-being in Hmong tradition are contingent upon pleasing spirits and ancestors. While most diseases are...
2.
Zhang H, Graiser M, Hutcherson D, Dada M, McMillan S, Ali Z, et al.
Biol Blood Marrow Transplant
. 2012 Feb;
18(8):1287-94.
PMID: 22370160
The clinical advantage of pharmacokinetic (PK)-directed-based dosing on intravenous (i.v.) versus oral busulfan-related toxicity and survival remains unclear. We performed a retrospective cohort study of sequential cohorts of patients comparing...
3.
Lima L, Arellano M, Holloway S, Shepard M, McMillan S, Khoury H
J Blood Med
. 2012 Jan;
1:221-5.
PMID: 22282699
Dasatinib (DAS) is a well tolerated oral dual SRC inhibitor with remarkable activity against all phases of imatinib-resistant chronic myeloid leukemia (CML). This paper focuses on the activity of DAS...
4.
Lonial S, Kaufman J, Tighiouart M, Nooka A, Langston A, Heffner L, et al.
Clin Cancer Res
. 2010 Aug;
16(20):5079-86.
PMID: 20739431
Purpose: We did a randomized phase I/II trial designed to evaluate the safety and efficacy of combining the proteasome inhibitor bortezomib with high-dose melphalan as the conditioning for high-dose therapy...
5.
Jacobsohn D, Hallick J, Anders V, McMillan S, Morris L, Vogelsang G
Am J Hematol
. 2003 Sep;
74(2):119-24.
PMID: 14508798
Acute and chronic graft-versus-host disease (GVHD) remain major barriers to successful hematopoietic stem cell transplantation (SCT). TNF-alpha has been implicated in the pathogenesis of GVHD and TNF-alpha blockade has been...